跳至主要内容
临床试验/IRCT2012073110453N1
IRCT2012073110453N1已完成2 期

comprasion of antiplatelet activity of garlic tablets with cardioprotective dose of aspirin (80mg/day)in healthy volunteers

Pharmaceutical Siences Reseaserch0 个研究点目标入组 62 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Exclusion criteria applied to individuals who had cardiovascular disease, been using aspirin, clopidogrel and nonsteroidal anti inflammatory drugs ( NSAIDS) in the last 2 weeks ago , thrombocytopenia(platelet<100 × 10 3 platelets /mm3 ), anemia(hemoglobin<10g/dl),abnormal lipid profile[total chlosterol = 200 mg/dl , LDL-C =100mg/dl , TG = 200 mg/dl HDL= 45 mg/dl(male) and = 55 mg/dl(female) ], Diabetes mellitus (FBS = 126 mg/ dl confirmed by repeating the test), and renal failure[Serum creatinine = 2mg/dl (female) and Serum creatinine=2.5 mg/dl (male)]
  • inclusion criteria : 62 healthy individuals(non diabetic ? normal lipid profile ? without any cardiovascular disease and coagulation disordes ?non used aspirin, clopidogrel and nonsteroidal anti inflammatory drugs ( NSAIDS) in the last 2 weeks ago aged 20-50 years old were enrolled in this clinical trial.

排除标准

  • 未提供

研究者

发起方
Pharmaceutical Siences Reseaserch

相似试验